Skip to main content

Advertisement

SpringerLink
Log in

Epidemiology of Neuropathic Pain and Its Impact on Quality of Life

  • Neuropathic Pain (R Raja, Section editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available. In one sense, neuropathic pain describes a symptom or a mechanism, rather than a specific disease; on the other hand, there are sufficient similarities in the effects and response to treatment between different causes to make it worthwhile to consider neuropathic pain as a distinct condition. However, there are important specific disease-based factors that need to be considered separately. Estimates of prevalence that are based on specific causes of neuropathic pain tend to be lower (1–2%) than those that are based on reports of the classic symptoms (6–8%), and further methodological research is needed. All neuropathic pain is associated with poor general health, comparable with other severe chronic diseases. The importance of newly proposed risk factors, including genetic factors, still needs to be assessed at a population level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Last JM. A dictionary of epidemiology. 3rd ed. Oxford: Oxford University Press; 1995.

    Google Scholar 

  2. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.

    Article  PubMed  CAS  Google Scholar 

  3. •• Jensen TS, Baron R, Haanpaa M, et al. A new definition of neuropathic pain. Pain. 2011;152:2204–5. This article clarifies and discusses the new IASP definition of neuropathic pain.

    Article  PubMed  Google Scholar 

  4. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP press; 1994.

    Google Scholar 

  5. Haanpaa ML, Backonja MM, Bennett MI, et al. Assessment of neuropathic pain in primary care. Am J Med. 2009;122:S13–21.

    Article  PubMed  Google Scholar 

  6. •• Haanpaa M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152:14–27. This article provides a wide-ranging, in-depth review of all aspects of neuropathic pain assessment based on current evidence.

    Article  PubMed  Google Scholar 

  7. Bennett MI, Smith BH, Torrance N, Lee AJ. Can pain be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain. 2006;122:289–94.

    Article  PubMed  Google Scholar 

  8. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389–400.

    Article  PubMed  CAS  Google Scholar 

  9. Hansson PT, Dickenson AH. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain. 2005;113:251–4.

    Article  PubMed  Google Scholar 

  10. Daniel HC, Narewska J, Serpell M, et al. Comparison of psychological and physical function in neuropathic pain and nociceptive pain: implications for cognitive behavioral pain management programs. Eur J Pain. 2008;12:731–41.

    Article  PubMed  Google Scholar 

  11. • Baron R, Tolle TR, Gockel U, et al. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain. 2009;146:34–40. This article identifies five distinct subtypes of neuropathic pain, based on symptoms and sensory profiles. It is not clear yet whether these have implications for management and response to treatment.

    Article  PubMed  Google Scholar 

  12. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neuro Dis. 1998;5:209–27.

    Article  CAS  Google Scholar 

  13. Gremeau-Richard C, Dubray C, Aublet-Cuvelier B, et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain. 2010;149:27–32.

    Article  PubMed  Google Scholar 

  14. Scholz J, Woolf CJ. Can we conquer pain? Nat Neurosci. 2002;5:S1062–7.

    Article  Google Scholar 

  15. Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology. 1998;51:1682–8.

    PubMed  CAS  Google Scholar 

  16. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA. 1998;280:1590–5.

    Article  PubMed  CAS  Google Scholar 

  17. Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004;251:1260–6.

    Article  PubMed  CAS  Google Scholar 

  18. Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68:515–21.

    Article  PubMed  CAS  Google Scholar 

  19. Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34:672–80.

    Article  PubMed  CAS  Google Scholar 

  20. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull. 1991;47:644–66.

    PubMed  CAS  Google Scholar 

  21. Bennett GJ. Neuropathic pain: an overview. In: Borsook D, editor. Molecular biology of pain. Seattle: IASP Press; 1997. p. 109–13.

    Google Scholar 

  22. Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18:343–9.

    Article  PubMed  Google Scholar 

  23. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  24. Bowsher D. The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain. 1999;3:335–42.

    Article  PubMed  Google Scholar 

  25. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–22.

    Article  PubMed  Google Scholar 

  26. Choo PW, Galil K, Donahue JG, et al. Risk factors for postherpetic neuralgia. Arch Intern Med. 1997;157:1217–24.

    Article  PubMed  CAS  Google Scholar 

  27. Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911–20.

    Article  PubMed  Google Scholar 

  28. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127:199–203.

    Article  PubMed  Google Scholar 

  29. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7:281–9.

    Article  PubMed  Google Scholar 

  30. Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380–7.

    Article  PubMed  Google Scholar 

  31. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain. 2007;23:143–9.

    Article  PubMed  Google Scholar 

  32. • Attal N, Lanteri-Minet M, Laurent B, et al. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain. 2011;152:2836–43. This paper is a follow-up to the prevalence study (Bouhassira et al. [30]) and confirms the detrimental impact of neuropathic pain within the general population.

    Article  PubMed  Google Scholar 

  33. Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. NEJM. 2005;352:341–50.

    Article  PubMed  CAS  Google Scholar 

  34. Jensen TS, Backonja MM, Hernandez Jimenez S, et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes Vasc Dis Res. 2006;3:108–19.

    Article  Google Scholar 

  35. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62:1545–51.

    PubMed  Google Scholar 

  36. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618–25.

    Article  PubMed  Google Scholar 

  37. Dieleman JP, Kerklaan J, Huygen FJ, et al. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008;137:681–8.

    Article  PubMed  Google Scholar 

  38. Hall GC, Caroll, Parry D, et al. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002–2005. BMC Fam Pract. 2008;9:26.

    Article  PubMed  Google Scholar 

  39. Smith BH, Torrance N. Epidemiology of neuropathic pain. Pain Manage. 2011;1:87–96.

    Article  Google Scholar 

  40. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6:149–58.

    Article  PubMed  Google Scholar 

  41. Bouhassira D, Atta N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36.

    Article  PubMed  Google Scholar 

  42. Gustorff B, Dorner T, Likar R, et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand. 2008;52:132–6.

    Article  PubMed  CAS  Google Scholar 

  43. Yawn BP, Wollan PC, Weingarten TN, et al. The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population. Pain Med. 2009;10:586–93.

    Article  PubMed  Google Scholar 

  44. Toth C, Lander J, Wiebe S. The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Med. 2009;10:918–29.

    Article  PubMed  Google Scholar 

  45. Opstelten W, Mauritz JW, de Wit NJ, et al. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19:471–5.

    Article  PubMed  Google Scholar 

  46. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341–9.

    Article  PubMed  Google Scholar 

  47. Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137:38–47.

    Article  PubMed  CAS  Google Scholar 

  48. Cebrian-Cuenca AM, Diez-Domingo J, San-Martin-Rodriguez M, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis. 2011;11:302.

    Article  PubMed  Google Scholar 

  49. Wu EQ, Borton J, Said G, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France. Curr Med Res Opin. 2007;23:2035–42.

    Article  PubMed  CAS  Google Scholar 

  50. Younes M, Bejia I, Aguir Z, et al. Prevalence and risk factors of disk-related sciatica in an urban population in Tunisia. Joint Bone Spine. 2006;73:538–42.

    Article  PubMed  Google Scholar 

  51. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007;68:1178–82.

    Article  PubMed  Google Scholar 

  52. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350–4.

    Article  PubMed  Google Scholar 

  53. • Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149:338–44. This paper confirms the hypothesis that patients with neuropathic pain experience low health utilities and, therefore, low HRQoL.

    Article  PubMed  Google Scholar 

  54. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573–81.

    Article  PubMed  Google Scholar 

  55. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9:660–74.

    Article  PubMed  Google Scholar 

  56. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. NEJM. 2005;352:2271–84.

    Article  PubMed  CAS  Google Scholar 

  57. Bouhassira D, Chassany O, Gaillat J, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2011;153:342–9.

    Article  PubMed  Google Scholar 

  58. Dworkin RH, Gnann JW, Oaklander AL, et al. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008;9:S37–44.

    Article  PubMed  Google Scholar 

  59. Harpaz R, Ortega-Sanchez IR, Seward JF, et al. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and mortality weekly report. Centers for Disease Control. 2008;57:1–30.

    Google Scholar 

  60. O’Connor AB, Schwid SR, Herrmann DN, et al. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain. 2008;137:96–111.

    Article  PubMed  Google Scholar 

  61. Barrett AM, Lucero MA, Le T, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007;8:S50–62.

    Article  PubMed  Google Scholar 

  62. Jih JS, Chen YJ, Lin MW, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol. 2009;89:612–6.

    Article  PubMed  Google Scholar 

  63. Mehra M, Hill K, Nicholl D, Schadrack J: The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. J Med economics 2011, Dec 5. [Epub ahead of print]

  64. Schmidt CO, Schweikert B, Wenig CM, et al. Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain. 2009;13:1030–5.

    Article  PubMed  Google Scholar 

  65. Dworkin RH, Panarites CJ, Armstrong EP, et al. Healthcare utilization in people with postherpetic neuralgia and painful diabetic peripheral neuropathy. J Am Geriatr Soc. 2011;59:827–36.

    Article  PubMed  Google Scholar 

Download references

Disclosures

Dr. Blair H. Smith has received a grant from Pfizer; has received honoraria from Eli Lilly; has received payment for the development of educational presentations from Grünenthal; and has received travel expense compensation from Grünenthal and Eli Lilly. Dr. Nicola Torrance received a grant from Pfizer.

Author information

Authors and Affiliations

  1. University of Dundee, Medical Research Institute, Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK

    Blair H. Smith & Nicola Torrance

Authors
  1. Blair H. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicola Torrance
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Blair H. Smith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, B.H., Torrance, N. Epidemiology of Neuropathic Pain and Its Impact on Quality of Life. Curr Pain Headache Rep 16, 191–198 (2012). https://doi.org/10.1007/s11916-012-0256-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-012-0256-0

Keywords

Search

Navigation